Schonberger L, Kaplan J, Kim-Farley R, Moore M, Eddins D, Hatch M (1984). “Control of paralytic poliomyelitis in the United States”. Rev. Infect. Dis.6 Suppl 2: S424?6. doi:10.1093/clinids/6.Supplement_2.S424. PMID6740085.
Sabin A; Ramos-Alvarez M; Alvarez-Amezquita J et al. (1960). “Live, orally given poliovirus vaccine.Effects of rapid mass immunization on population under conditions of massive enteric infection with other viruses”. JAMA173 (14): 1521?6. doi:10.1001/jama.1960.03020320001001. PMID14440553.
Sabin AB (1987). “Role of my cooperation with Soviet scientists in the elimination of polio: possible lessons for relations between the U.S.A. and the USSR”. Perspect. Biol. Med.31 (1): 57?64. doi:10.1353/pbm.1987.0023. PMID3696960.
Kew O et al. (2002). “Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus”. Science296 (5566): 356?9. doi:10.1126/science.1068284. PMID11896235.
Plotkin SA; Modlin, J. F.; Plotkin, S. A. (2001). “CHAT oral polio vaccine was not the source of human immunodeficiency virus type 1 group M for humans”. Clin. Infect. Dis.32 (7): 1068?84. doi:10.1086/319612. PMID11264036.
Schonberger L, Kaplan J, Kim-Farley R, Moore M, Eddins D, Hatch M (1984). “Control of paralytic poliomyelitis in the United States”. Rev. Infect. Dis.6 Suppl 2: S424?6. doi:10.1093/clinids/6.Supplement_2.S424. PMID6740085.
Sabin A; Ramos-Alvarez M; Alvarez-Amezquita J et al. (1960). “Live, orally given poliovirus vaccine.Effects of rapid mass immunization on population under conditions of massive enteric infection with other viruses”. JAMA173 (14): 1521?6. doi:10.1001/jama.1960.03020320001001. PMID14440553.
Sabin AB (1987). “Role of my cooperation with Soviet scientists in the elimination of polio: possible lessons for relations between the U.S.A. and the USSR”. Perspect. Biol. Med.31 (1): 57?64. doi:10.1353/pbm.1987.0023. PMID3696960.
Benison S (1982). “International medical cooperation: Dr. Albert Sabin, live poliovirus vaccine and the Soviets”. Bull Hist Med56 (4): 460?83. PMID6760938.
Hammon W, Coriell L, Wehrle P, Stokes J; Coriell; Wehrle; Stokes Jr (1953). “Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. IV. Final report of results based on clinical diagnoses”. J Am Med Assoc151 (15): 1272?85. PMID13034471.
Kew O et al. (2002). “Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus”. Science296 (5566): 356?9. doi:10.1126/science.1068284. PMID11896235.
Olin P, Giesecke J (1998). “Potential exposure to SV40 in polio vaccines used in Sweden during 1957: no impact on cancer incidence rates 1960 to 1993”. Dev Biol Stand94: 227?33. PMID9776244.
Plotkin SA; Modlin, J. F.; Plotkin, S. A. (2001). “CHAT oral polio vaccine was not the source of human immunodeficiency virus type 1 group M for humans”. Clin. Infect. Dis.32 (7): 1068?84. doi:10.1086/319612. PMID11264036.
